| Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic … KC Herold, SE Gitelman, MR Ehlers, PA Gottlieb, CJ Greenbaum, ... Diabetes 62 (11), 3766-3774, 2013 | 388 | 2013 |
| Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function SA Long, M Rieck, S Sanda, JB Bollyky, PL Samuels, R Goland, ... Diabetes 61 (9), 2340-2348, 2012 | 324 | 2012 |
| 4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer N Nagy, HF Kuipers, AR Frymoyer, HD Ishak, JB Bollyky, TN Wight, ... Frontiers in immunology 6, 123, 2015 | 299 | 2015 |
| B-lymphocyte depletion with rituximab and β-cell function: two-year results MD Pescovitz, CJ Greenbaum, B Bundy, DJ Becker, SE Gitelman, ... Diabetes care 37 (2), 453-459, 2014 | 276 | 2014 |
| Is the quality of diabetes care better in a diabetes clinic or in a general medicine clinic? M Ho, M Marger, J Beart, I Yip, P Shekelle Diabetes care 20 (4), 472-475, 1997 | 246 | 1997 |
| Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment T Orban, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ... Diabetes care 37 (4), 1069-1075, 2014 | 197 | 2014 |
| Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making. PG Shekelle, RL Kravitz, J Beart, M Marger, M Wang, M Lee Health services research 34 (7), 1429, 2000 | 191 | 2000 |
| Comparison of screening tests for non-insulin-dependent diabetes mellitus RL Hanson, RG Nelson, DR McCance, JA Beart, MA Charles, DJ Pettitt, ... Archives of internal medicine 153 (18), 2133-2140, 1993 | 135 | 1993 |
| Use of a “fuzzy logic” controller in a closed-loop artificial pancreas R Mauseth, IB Hirsch, J Bollyky, R Kircher, D Matheson, S Sanda, ... Diabetes technology & therapeutics 15 (8), 628-633, 2013 | 124 | 2013 |
| The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation PL Bollyky, M Bogdani, JB Bollyky, RL Hull, TN Wight Current diabetes reports 12, 471-480, 2012 | 107 | 2012 |
| Association of clinical reactivity with sensitization to allergen components in multifood-allergic children S Andorf, MP Borres, W Block, D Tupa, JB Bollyky, V Sampath, A Elizur, ... The Journal of Allergy and Clinical Immunology: In Practice 5 (5), 1325-1334. e4, 2017 | 85 | 2017 |
| Remote lifestyle coaching plus a connected glucose meter with certified diabetes educator support improves glucose and weight loss for people with type 2 diabetes JB Bollyky, D Bravata, J Yang, M Williamson, J Schneider Journal of diabetes research 2018, 2018 | 80 | 2018 |
| Diabetes TrialNet and the Immune Tolerance Network. Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function SA Long, M Rieck, S Sanda, JB Bollyky, PL Samuels, R Goland, ... Diabetes 61 (9), 2340-2348, 2012 | 55 | 2012 |
| Opening clinical trial data: are the voluntary data-sharing portals enough? N Geifman, J Bollyky, S Bhattacharya, AJ Butte BMC medicine 13, 1-3, 2015 | 51 | 2015 |
| The pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice HF Kuipers, N Nagy, SM Ruppert, VG Sunkari, PL Marshall, JA Gebe, ... Clinical & Experimental Immunology 185 (3), 372-381, 2016 | 48 | 2016 |
| Reduced medical spending associated with increased use of a remote diabetes management program and lower mean blood glucose values CM Whaley, JB Bollyky, W Lu, S Painter, J Schneider, Z Zhao, X He, ... Journal of Medical Economics 22 (9), 869-877, 2019 | 46 | 2019 |
| Use of a connected glucose meter and certified diabetes educator coaching to decrease the likelihood of abnormal blood glucose excursions: the Livongo for Diabetes Program J Downing, J Bollyky, J Schneider Journal of medical Internet research 19 (7), e234, 2017 | 44 | 2017 |
| Review of environmental impact on the epigenetic regulation of atopic diseases S Sabounchi, J Bollyky, K Nadeau Current allergy and asthma reports 15, 1-10, 2015 | 41 | 2015 |
| Short-term IL-1β blockade reduces monocyte CD11b integrin expression in an IL-8 dependent fashion in patients with type 1 diabetes S Sanda, J Bollyky, N Standifer, G Nepom, JA Hamerman, C Greenbaum Clinical immunology 136 (2), 170-173, 2010 | 28 | 2010 |
| Heterogeneity in recent‐onset type 1 diabetes–a clinical trial perspective JB Bollyky, P Xu, AJ Butte, DM Wilson, CA Beam, CJ Greenbaum, ... Diabetes/metabolism research and reviews 31 (6), 588-594, 2015 | 27 | 2015 |
